down arrow

Lincoln Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
552.90
14.65 (2.72%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 13.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
308.50
291.61
264.08
249.66
229.86
209.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
308.50
291.61
264.08
249.66
229.86
209.50
Raw Material Cost
109.85
92.36
95.29
74.80
62.60
71.33
Purchase of Finished goods
35.19
35.40
38.00
44.42
40.03
26.89
(Increase) / Decrease In Stocks
-2.50
9.91
-4.31
-1.90
8.52
0.66
Employee Cost
56.86
51.41
45.98
32.81
26.54
30.66
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
57.99
50.66
43.31
44.93
40.24
36.23
Total Expenditure (Excl Depreciation)
257.38
239.74
218.27
195.07
177.93
165.77
Operating Profit (PBDIT) excl Other Income
51.12
51.87
45.81
54.59
51.93
43.73
Other Income
20.39
16.39
12.22
5.47
2.40
3.82
Operating Profit (PBDIT)
71.51
68.26
58.03
60.06
54.33
47.55
Interest
0.79
0.81
0.55
0.58
0.60
1.23
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
70.72
67.45
57.48
59.48
53.73
46.32
Depreciation
6.45
5.13
4.49
3.91
3.77
3.62
Profit Before Tax
64.26
62.32
52.99
55.57
49.96
42.70
Tax
14.26
15.65
14.26
14.84
13.78
11.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.00
46.67
38.72
40.73
36.18
31.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.00
46.67
38.72
40.73
36.18
31.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-0.01
-0.01
-0.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.00
46.67
38.72
40.72
36.17
31.58
Equity Capital
20.03
20.03
20.03
20.00
20.00
20.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
393.02
0.00
0.00
Earnings per share (EPS)
24.96
23.3
19.33
20.36
18.09
15.79
Diluted Earnings per share
24.96
23.3
19.33
20.36
18.08
15.79
Operating Profit Margin (Excl OI)
16.57%
17.79%
17.35%
21.87%
22.59%
20.87%
Gross Profit Margin
22.92%
23.13%
21.77%
23.82%
23.38%
22.11%
PAT Margin
16.21%
16.0%
14.66%
16.31%
15.74%
15.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 5.79% vs 10.42% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 7.14% vs 20.53% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is -1.45% vs 13.23% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is -2.47% vs 47.27% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of Lincoln Pharma. With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
308.50
5,969.93
-5,661.43
-94.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
308.50
5,969.93
-5,661.43
-94.83%
Raw Material Cost
109.85
934.97
-825.12
-88.25%
Purchase of Finished goods
35.19
857.27
-822.08
-95.90%
(Increase) / Decrease In Stocks
-2.50
-104.82
102.32
97.61%
Employee Cost
56.86
1,280.21
-1,223.35
-95.56%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
57.99
1,470.50
-1,412.51
-96.06%
Total Expenditure (Excl Depreciation)
257.38
4,438.13
-4,180.75
-94.20%
Operating Profit (PBDIT) excl Other Income
51.12
1,531.80
-1,480.68
-96.66%
Other Income
20.39
210.03
-189.64
-90.29%
Operating Profit (PBDIT)
71.51
1,741.83
-1,670.32
-95.89%
Interest
0.79
18.01
-17.22
-95.61%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
70.72
1,723.82
-1,653.10
-95.90%
Depreciation
6.45
213.36
-206.91
-96.98%
Profit Before Tax
64.26
1,510.46
-1,446.20
-95.75%
Tax
14.26
314.99
-300.73
-95.47%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
50.00
1,195.47
-1,145.47
-95.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
50.00
1,195.47
-1,145.47
-95.82%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
0.00
-11.99
11.99
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.00
1,189.96
-1,139.96
-95.80%
Equity Capital
20.03
40.06
-20.03
-50.00%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
24.96
29.70
-4.74
-15.96%
Diluted Earnings per share
24.96
29.65
-4.69
-15.82%
Operating Profit Margin (Excl OI)
16.57%
25.66%
0.00
-9.09%
Gross Profit Margin
22.92%
28.88%
0.00
-5.96%
PAT Margin
16.21%
20.13%
0.00
-3.92%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 308.50 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 5.79% vs 10.42% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 50.00 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 7.14% vs 20.53% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.12 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -1.45% vs 13.23% in Sep 2023

Half Yearly - Interest
Interest 0.79 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -2.47% vs 47.27% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.57%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023